While the concept is well established and several RNAi drugs have reached the clinic, their effectiveness has often been limited by the challenge of delivering fragile RNA molecules intact to the ...

In a leap that blurs the line between science fiction and cellular biology, scientists have turned a mysterious structure ...

Moderna, Inc. vs. Novavax, Inc.: cost cuts, vaccine pipeline catalysts, and valuations. Click for this comparison of NVAX and ...

Korro Bio (NASDAQ:KRRO) used its Analyst Day to outline the rationale and development plans for KRRO-121, an RNA-editing therapeutic candidate the company believes could provide a new approach to ...

Skyhawk Therapeutics shared results for SKY-0515, a drug designed to lower huntingtin. The drug appeared generally safe, with ...

Yeast-based protein expression systems will likely play an important role in vaccine production during future pandemics.

Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi ...

An experimental drug custom-made to target the genetic mutations of individual tumors showed promise in treating aggressive ...

Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine - which designs nanotechnology-based platforms for clinical translation across specialties - developed a ...

How do immune cells strike a balance, unleashing rapid attacks against pathogens or cancer, while avoiding damage to healthy cells? Research into an immune kill switch holds potential for controlling ...

A single enzyme that can generate all four nucleoside triphosphates, the building blocks of ribonucleic acid (RNA), has been ...

Now, it’s worth noting Stock Advisor’s total average return is 930 % — a market-crushing outperformance compared to 192% for ...